https://investor.ironwoodpharma.com/press-releases/press-release-details/2019/Ironwood-Pharmaceuticals-and-Allergan-Initiate-Patient-Dosing-in-Phase-II-Clinical-Trial-of-MD-7246-in-Patients-with-Abdominal-Pain-Associated-with-IBS-D/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- June 3, 2019